RT Journal Article
T1 Kinesiophobia Levels in Patients with Parkinson’s Disease: A Case-Control Investigation
A1 Jiménez Cebrián, Ana María
A1 Becerro de Bengoa Vallejo, Ricardo
A1 Losa Iglesias, Marta Elena
A1 Labra, Carmen de
A1 Calvo Lobo, César
A1 Palomo López, Patricia
A1 Martínez Jiménez, Eva María
A1 Navarro Flores, Emmanuel
AB Background: Kinesiophobia can be an obstacle to physical and motor activity in patients with Parkinson’s disease (PD). PD affects patients’ independence in carrying out daily activities. It also impacts a patient’s biopsychosocial well-being. The objective of this study was to analyze the levels and scores of kinesiophobia in PD patients and compare them with healthy volunteers. Methods: We deployed a case-control study and recruited 124 subjects (mean age 69.18 ± 9.12). PD patients were recruited from a center of excellence for Parkinson’s disease (cases n = 62). Control subjects were recruited from the same hospital (control n = 62). Kinesiophobia total scores and categories were self-reported using the Spanish version of the Tampa Scale of Kinesiophobia (TSK-11). Results: Differences between cases and control groups were analyzed using the Mann–Whitney U test. Statistically significant differences (p < 0.05) were shown between groups when comparing kinesiophobia categories (or levels) and total scores, revealing higher kinesiophobia symptoms and levels in PD patients. All of the PD patients reported some degree of kinesiophobia (TSK-11 ≥ 18), while the majority of PD patients (77.3%) had kinesiophobia scores rated as moderate to severe (TSK-11 ≥ 25). On the other hand, ~45.1% of controls reported no or slight kinesiophobia and 53.2% reported moderate kinesiophobia. Conclusions: Total kinesiophobia scores were significantly higher in PD patients compared with healthy controls, with moderate to severe kinesiophobia levels prevailing in PD patients. Therefore, individuals living with PD should be evaluated and controlled in order to detect initial kinesiophobia symptoms.
PB MPDI
SN 1660-4601
YR 2021
FD 2021-04-30
LK https://hdl.handle.net/20.500.14352/6938
UL https://hdl.handle.net/20.500.14352/6938
LA eng
NO Generalitat Valenciana
DS Docta Complutense
RD 21 ago 2024